September 5, 2025 · Form 4 insider transaction
Huizenga Theodore Alan sold 84 shares of Ultragenyx Pharmaceutical Inc. at $31.39 per share, a transaction worth $2.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Represents shares sold to pay required tax withholdings due to the vesting of RSUs.; Includes 266 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.; Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.